Chemokine receptor CCR5 and CXCR4 might influence virus replication during IBDV infection.

[1]  M. Dabrowska,et al.  The expression of the chemokine receptor CCR5 in tick-borne encephalitis , 2016, Journal of Neuroinflammation.

[2]  F. Bachelerie,et al.  Symptomatic Improvement in Human Papillomavirus-Induced Epithelial Neoplasia by Specific Targeting of the CXCR4 Chemokine Receptor. , 2016, The Journal of investigative dermatology.

[3]  A. Somasunderam,et al.  Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial , 2016, PLoS pathogens.

[4]  R. Rocha,et al.  Dengue virus requires the CC‐chemokine receptor CCR5 for replication and infection development , 2015, Immunology.

[5]  Hyun Kook Cho,et al.  Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF‐1 , 2014, FEBS letters.

[6]  C. Wu,et al.  Chicken melanoma differentiation-associated gene 5 (MDA5) recognizes infectious bursal disease virus infection and triggers MDA5-related innate immunity , 2014, Archives of Virology.

[7]  Nouri Neamati,et al.  Small Molecule Inhibitors of CXCR4 , 2013, Theranostics.

[8]  A. Kapatkin,et al.  Long‐term administration of AMD3100, an antagonist of SDF‐1/CXCR4 signaling, alters fracture repair , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  N. Fujii,et al.  Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). , 2012, Organic & biomolecular chemistry.

[10]  J. Murray,et al.  Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc , 2012, PloS one.

[11]  C. Ou,et al.  Protocatechuic acid, a new active substance against the challenge of avian infectious bursal disease virus. , 2012, Poultry science.

[12]  Yuan-zhi Yuan,et al.  [Anti-angiogenesis effect of AMD3100 in oxygen-induced retinopathy mice]. , 2012, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[13]  R. Selvaraj,et al.  Chemokine receptor CCR7 and CXCR5 mRNA in chickens following inflammation or vaccination. , 2011, Poultry science.

[14]  M. Khatri,et al.  Differential modulation of cytokine, chemokine and Toll like receptor expression in chickens infected with classical and variant infectious bursal disease virus , 2011, Veterinary research.

[15]  F. Sallusto,et al.  Chemokines and leukocyte traffic , 2008, Nature Immunology.

[16]  R. Jk,et al.  CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature. , 2007 .

[17]  B. Lambrecht,et al.  Pivotal role of ChIFNγ in the pathogenesis and immunosuppression of infectious bursal disease , 2007 .

[18]  John R. Young,et al.  Transcriptional Profiling Reveals a Possible Role for the Timing of the Inflammatory Response in Determining Susceptibility to a Viral Infection , 2006, Journal of Virology.

[19]  R. Wong,et al.  Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. , 2006, Biochemical pharmacology.

[20]  P. Kaiser,et al.  Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa. , 2006, Viral immunology.

[21]  K. Handberg,et al.  Transcriptional profiles of chicken embryo cell cultures following infection with infectious bursal disease virus , 2006, Archives of Virology.

[22]  Michael S Saag,et al.  Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1 , 2005, Nature Medicine.

[23]  S. Sze,et al.  Genomic organization, annotation, and ligand-receptor inferences of chicken chemokines and chemokine receptor genes based on comparative genomics , 2005, BMC Genomics.

[24]  D. Burt,et al.  In-silico identification of chicken immune-related genes , 2004, Immunogenetics.

[25]  J. Kwang,et al.  Antigenic and Molecular Characterization of Recent Infectious Bursal Disease Virus Isolates in China , 2002, Virus Genes.

[26]  A. Zlotnik,et al.  Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.

[27]  S. Rautenschlein,et al.  Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery , 2002, Archives of Virology.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  Thomas Boehm,et al.  Chemokines define distinct microenvironments in the developing thymus , 2000, European journal of immunology.

[30]  In-Jeong Kim,et al.  Characteristics of Bursal T Lymphocytes Induced by Infectious Bursal Disease Virus , 2000, Journal of Virology.